1 |
Bar-on, H. and P. S. Roheim. 1976. Hyperlipidemia in streptozotocin-treated rats. Diabetes 25: 509- 515.
|
2 |
Cavazzoni, V. and A. Adami. 1992. Exopolysaccharides produced by mycelial edible mushrooms. Ital J. Food Sci. 1: 9-15.
|
3 |
Desbuquois, B. and G. D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocr. 33: 732- 738.
|
4 |
Duncan, D. M. 1957. Multiple-range tests for correlated and heteroscedastic means. Biometrics 13: 164- 170.
DOI
ScienceOn
|
5 |
Foster, D. W. and J. D. MaGarry. 1983. The metabolic derangements and treatment of diabetic ketoacidosis. N. Engl. J. Med. 309: :.59- 164.
|
6 |
Fridewald, W. T, R. I. Levy, and D. S. Fedreicson. 1979. Estimation of concentration of low density cholesterol in plasma, without use of preparative ultracentrifuse. Clin. Chem. 18: 499-508.
|
7 |
Garg, A and S. -M. Grundy. 1990. Management of hyperlipidemia in NIDDM. Diabetes Care 13: 153-169.
|
8 |
Gray, A. M. and P. R. Flatt. 1998. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J. Endocrinol. 157: 259- 266.
|
9 |
Grey, N. J., I. Kars, and D. M. Kipnis. 1975. Physiologic mechanism in the development of starvation ketosis in man. Diabetes 24: 10- 16.
|
10 |
Hikino, H. and T. Mizuno. 1989. Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies. Planta Med. 55: 385- 389.
|
11 |
Niall, M. G., A M. Rosaleen, O. Daphne, B. C. Patrick, H. J. Alan, and H. Gerald. 1990. Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes 39: 626- 636.
|
12 |
Yang, B. K, J. B. Park, and C. H. Song. 2002. Hypolipidemic effect of exo-polymer produced in submerged mycelial culture of five different mushrooms. J. Microbiol. Biotechnol. 12: 957-961.
|
13 |
Zhang, X. H., H. B. Hu, Y L. Tang, R. S. Huang, J. F. Luo, and B. K Hur. 2002. The hepartoprotective effects of polysaccharides isolated from submerged fermentation of Ganoderma lucidum. J. Microbiol. Biotechnol. 12: 367-370.
|
14 |
Folch, J., M. Lees, and G. H. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipid from animal tissue. J. Bio!. Chem. 226: 497-503.
|
15 |
Yang, B. K, S. C. Jeong, and C. H. Song. 2002. Hypolipidemic effect of exo- and endo-biopolymers produced from submerged mycelial culture of Ganoderma lucidum in rats. J. Microbiol. Biotechnol. 12: 872- 877.
|
16 |
Sale, F. O., S. Marchesini, P. H. Fishman, and B. A Berra. 1984. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal. Biochem. 142: 347- 350.
|
17 |
Furuse, M., C. Kimura, R. T Mabayo, H. Takahashi, and J. Okumara. 1993. Dietary sorbose prevents and improves hyperglycemia in genetically diabetic mice. J. Nutr. 123: 59-65.
PUBMED
|
18 |
Hikino, H., C. Konno, Y Mirin, and T. Hayashi. 1985. Isolation and hypoglycemic activity of gamodemas A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med. 4: 339-340.
|
19 |
Raabo, E. and T. C. Terkildsen. 1960. On the enzymatic determination of blood glucose. Scand. J. Clin. Lab. Invest. 12: 402- 407.
|
20 |
Wang, S. Y., M. L. Hsu, H. C. Hsu, C. H. Tzeng, S. S. Lee, M. S. Shiao, and C. K Ho. 1997. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 17: 699-705.
|
21 |
Yoon, S. Y, S. K. Eo, Y. S. Kim, and S. S. Han. 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch. Pharm. Res. 17: 438-442.
|
22 |
Patocka, J. 1999. Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modem medicine. Acta Medica 42: 123- 125.
|
23 |
Junod, A., A. E. Lambert, L. Orci, R. Pictet, A. E. Gonet, and A. E. Renold. 1967. Studies of the diabetogenic action of streptozotocin. Proc. Soc. Exp. Bioi. Med. 126: 201-205.
|
24 |
Mendola, J., J. R. Wright, and P. E. Lacy. 1989. Oxygen free radical scavenger and immune destruction of murine lowdose STZ-induced insulitis. Diabetes 38: 379- 385.
|
25 |
Bierman, E. L. 1992. George Lyman Duff memorial lecture: Atherogenesis in diabetes. Arteriosclerosis Thromb. 12: 647- 656.
|
26 |
Bursch, W. and R. Schulte-Hermann. 1986. Cytoprotective effect of the prostacyclin derivative iloprost against liver cell death induced by the hepatotoxins carbon terachloride and bromobenzen. Klin. Wochenschr. 64(SuppI. 7): 47-50.
|
27 |
Goldberg, R. B. 1981. Lipid disorders in diabetes. Diabetes Care 4: 561-572.
DOI
PUBMED
ScienceOn
|
28 |
Kimura, Y., H. Okuda, and S. Arichi. 1988. Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. Planta Med. 54: 290- 294.
|
29 |
Reaven, K. M. 1987. Abnormal lipoprotein metabolism in non-insulin dependent diabetes mellitus. Am. J. Med. 83: 31-40.
PUBMED
|
30 |
Yang, B. K, S. C. Jeong, J. B. Park, S. P. Cho, H. J. Lee, S. Das, J. W. Yun, W. J. Lim, and C. H. Song. 2001. Swimming endurance capacity of mice after administration of exo-polymer produced from submerged mycelial culture of Ganoderma lucidum. J. Microbiol. Biotechnol. 11: 902905.
|
31 |
Kabir, Y, S. Kimura, and T. Tomura. 1988. Dietary effect of Ganoderma lucidum mushrooms on blood pressure and lipid levels in spontaneously hypertensive rats. J. Nutr. Sci. Mitaminol. (Tokyo) 34: 433-438.
|
32 |
Lee, K. H., J. W. Lee, M. D. Han, H. Jeong, Y. I. Kim, and D. W. Oh. 1994. Correlation between anti-complementary and antitumor activity of the crude polysaccharide from Ganoderma lucidum IY009. Kor. J. Appl. Microbiol. Bioeng. 22: 45-51.
|
33 |
Van Hom, L. V. 1996. Lipid metabolism and choices for persons with diabetes. In Powers, M. A (ed.). Handbook of Diabetes Medical Nutrition Therapy. Aspen Publishers Inc., Gaithersburg, Maryland.
|
34 |
Hayes, T. M. 1972. Plasma lipoproteins in adult diabetes. Clin. Endoerinol. 1: 247-251.
DOI
PUBMED
|
35 |
Min, B. S., J. J. Gao, N. Nakamura, and M. Hattori. 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. 48: 1026-1033.
|
36 |
Takasu, N., I. Komiya, and T. Asawa. 1991. STZ and alloxan-induced H20 generation and DNA fragmentation in pancreatic islets. Diabetes 40: 1141- 1145.
|
37 |
Shon, K. H., S. H. Kim, and J. W. Choi. 1992. Pretreatment with nicotinamide to prevent the pancreatic enzymes changes by streptozotocin in rats. J. Korean Soc. Food Nutr. 21: 117- 123.
|